Mode
Text Size
Log in / Sign up
N/A N=20 Treatment

Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease

Peripheral Arterial Disease

Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Mar 2019
Primary outcome: Primary: Device Technical Success — 29 lesions

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
CorPath 200 System (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Corindus Inc.
Primary completion
Apr 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Device Technical Success
29
PRIMARY
Adverse Events
SECONDARY
Clinical Procedural Success
20
SECONDARY
Fluoroscopy Time
6.8
SECONDARY
Contrast Volume
73.3
SECONDARY
Total Procedure Time
45.5
SECONDARY
Interventional Procedure Time
23.4

Summary

This study evaluates the performance of the CorPath 200 System to deliver guide wires and balloons to blockages in the arteries of the leg.

Eligibility Criteria

Inclusion Criteria

  • General Inclusion
  • At least 18 years of age;
  • Symptomatic disease: presence of critical limb ischemia (including tissue loss or rest pain), or lifestyle-limiting claudication requiring intervention in iliac and/or superficial femoral arteries;
  • The subject or the legally authorized representative has been informed of the nature of the study and agrees to its provisions and has provided written informed consent.
  • Angiographic Inclusion

Presence of superficial femoral artery and/or iliac stenosis (>50%) or occlusion of up to 50 mm in length as determined by angiogram prior to index interventional procedure.

Exclusion Criteria

  • General Exclusion
  • Failure/inability/unwillingness to provide informed consent;
  • Target vessel has been previously treated with bypass;
  • Has an abdominal aortic aneurysm contiguous with the iliac artery target lesion;
  • Has contraindication to anticoagulation;
  • Has bleeding or a hypercoagulability disorder;
  • Thrombocytopenia;
  • Elevated international normalized ratio (>1.5);
  • Elevated serum creatinine (≥2.5 mg/dL);
  • Active infection;
  • Contraindication to contrast; or
  • Enrolled in concurrent clinical study.
  • Angiographic Exclusion
  • Target vessel:
  • shows evidence of previous dissection or perforation, or
  • has adjacent acute thrombus;
  • Lesion is highly calcified;
  • Lesion requires use of any atherectomy device during the procedure;
  • Has a pre-existing target artery aneurysm or perforation or dissection of the target artery prior to initiation of the interventional procedure.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02371785). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search